Shah Pritesh - Chief Growth Officer at NovoCure Ltd

Issuer-level insider activity

Role
Chief Growth Officer
Issuer ticker
NVCR on Nasdaq
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Shah Pritesh since 28 Aug 2025

Reported holdings for Shah Pritesh in NovoCure Ltd

Form 4 holding Chief Growth Officer

NovoCure Ltd

Security class
Ordinary Shares
Shares / value
124,511
Estimated value
$1,575,064
Report date
07 Nov 2023
Price
$12.65
Ownership
Direct

Transaction history for Shah Pritesh in NovoCure Ltd

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .